1.85 (-%)
As of Oct 31, 2024
Source:
Rafael Holdings, Inc., a Delaware corporation, is a holding company with interests in clinical and early-stage pharmaceutical companies, including an investment in Cornerstone Pharmaceuticals, Inc., formerly known as Rafael Pharmaceuticals Inc., a cancer metabolism-based therapeutics company, a majority equity interest in LipoMedix Pharmaceuticals Ltd.
Country | United States |
Headquarters | newark, new jersey |
Phone Number | (212) 658-1450 |
Industry | finance |
CEO | William Conkling |
Website | www.rafaelholdings.com |